Roche Estradiol III Assay Recalled Due to Fulvestrant Cross-Reactivity
Roche is recalling the Estradiol III assay because fulvestrant treatment causes falsely elevated estradiol results, potentially leading to incorrect patient management.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall involves a risk-of-harm product (medical diagnostic) where the hazard is incorrect clinical management due to false results, but no specific injuries or illnesses are reported in the source text.
Plain-English summary
Roche Diagnostics Operations, Inc. is recalling the Elecsys Estradiol III assay (REF 06656021 190) used on Elecsys and cobas e analyzers. The recall involves 23,630 units distributed nationwide in the US, including Puerto Rico. All lot numbers are affected.
The recall is due to a recently identified cross-reactivity where the drug fulvestrant increases the apparent concentration of estradiol in women being treated with it. This can result in falsely elevated estradiol levels. The source text indicates that if treatment with fulvestrant has been altered or discontinued as a result of these falsely elevated results, the recall is necessary to prevent incorrect clinical decisions.
Customers should be informed that fulvestrant will increase the apparent concentration of estradiol. The assay should not be used when monitoring patients being treated with fulvestrant.
The recalled product
- Product
- Estradiol III; Elecsys and cobas e analyzers; REF 06656021 190; M 6.5 mL, R1 9 mL, R2 9 mL, For USA: CONTENT M Streptavidin-coated microparticles 0.72 mg/ml; R1 Two biotinylated monoclonal anti-estradiol antibodies (rabbit) 2.5 ng/m and 4.5 ng/mL Mesterolone 130 ng/mL; R2 Estr
- Manufacturer
- Roche Diagnostics Operations, Inc.
- Affected units
- 23,630
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Elecsys Estradiol III: 06656021190
- all lot numbers are affected.
Distribution
Part of a larger recall action
This product is one of 2 recalled by Roche Diagnostics Operations, Inc. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Roche Diagnostics Operations, Inc.
See all →- HighRoche cobas analyzer may repeat previous results for spline calibrated assays
FDA (Devices) · 2026-03-11
- HighThyroid receptor immunoassay recalled over variable results across instrument platforms
FDA (Devices) · 2026-01-14
- HighMedical Device Homocysteine Test Assay Recalled for Calibration Defects
FDA (Devices) · 2024-11-27
- HighRoche Creatine Kinase test reagents recalled for calibration errors
FDA (Devices) · 2024-10-02
- HighRoche Tina-quant D-Dimer Test System Recalled for Inaccurate Results
FDA (Devices) · 2023-11-29
Same hazard · cross reactivity
See all →- HighFDA Recalls COVID-19 Antibody Test Kits for Increased False Positive Risk
FDA (Devices) · 2021-09-08
- ModerateCytocell Recalls Chromosome X Alpha-Satellite Probes Due to Cross-Reactivity
FDA (Devices) · 2021-05-05
- ModerateBeckman Coulter Recalls Synchron Opiate 2000 ng Reagent Due to Cross-Reactivity
FDA (Devices) · 2020-04-29
- ModerateTosoh Bioscience Recalls ST AIA-PACK Progesterone III Assay Kits
FDA (Devices) · 2018-03-07
- HighTosoh Bioscience Recalls Progesterone II Assay Kits Due to Cross-Reactivity
FDA (Devices) · 2018-03-07